CVS Health Corp vs Rush Street Interactive Inc — how do they compare? CVS Health Corp trades at $86.4 (market cap $112.29B), while Rush Street Interactive Inc trades at $19.81 (market cap $2.35B). The key difference: CVS Health Corp is far larger — about 47.8× Rush Street Interactive Inc's market cap, and CVS Health Corp pays a 3.03% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Rush Street Interactive Inc for 13 Days on average.
| CVS | RSI | |
|---|---|---|
Market Cap | $112.29B | $2.35B |
Volume | 7,763,676 | 2,219,374 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $34.52 |
52-Week Low | $70.08 | $15.89 |
Typical Hold Time | 83 Days | 13 Days |
Enterprise Value | $174.64B | $2.01B |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
RSI trades at $20.24, down 1.56% with bearish technical signals but strong analyst support. The company shows revenue growth from $1.13B in 2025 to $1.4B projected for 2026, though net income margin compressed from 2.93% to 2.33%. Recent Q2 2026 earnings beat expectations with $0.15 EPS versus $0.1499 expected. Technical indicators show mixed signals with moving averages bearish but oscillators neutral, while institutional activity includes BlackRock's $448M investment in August 2026.
The stock presents a compelling valuation gap with consensus price target of $34.88 representing 72% upside, supported by 77% buy ratings from analysts. Key risks include competitive pressures in online gaming and margin compression despite revenue growth. The company's participation in major industry conferences and strong institutional backing provides fundamental support for long-term growth prospects.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →